Search
for
Sort by
Research 421–450 of 1000+
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Use of low-level laser therapy as monotherapy or concomitant therapy for male and female Androgenetic alopecia
- Reflections on how wound healing-promoting effects of the hair follicle can be translated into clinical practice
- Low-level laser therapy for the treatment of androgenic alopecia: a review
- Update on the dermatologic use of systemic glucocorticosteroids
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- Redefining hormone resistance in prostate cancer
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Human hair keratins promote the regeneration of peripheral nerves in a rat sciatic nerve crush model
- The Clinical Presentation of Systemic Lupus Erythematosus
- Touch Receptors Undergo Rapid Remodeling in Healthy Skin
- Parkinson's disease and skin
- Thymosin β4 Promotes Dermal Healing
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Polycystic ovarian syndrome
- Post-finasteride syndrome: An emerging clinical problem
- Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature
- Biallelic HEPHL1 variants impair ferroxidase activity and cause an abnormal hair phenotype
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines
- INTERFERONS IN DERMATOLOGY
- The pathophysiology of delayed ejaculation
- Skin signs of systemic diseases
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Teriflunomide in multiple sclerosis: an update
- Topical absorption and systemic toxicity